[11C]Cyclopropyl-FLB 457 (cas 107188-66-9): A PET radioligand for low densities of dopamine D2 receptors
-
Add time:08/21/2019 Source:sciencedirect.com
(S)-5-Bromo-N-[(1-cyclopropylmethyl-2-pyrrolidinyl)methyl]-2,3-dimethoxybenzamide (4) has pico-molar in vitro binding affinity to D2 receptor (Ki (D2) = 0.003 nM) with lower affinity to D3 receptor (Ki (D3) = 0.22 nM). In this study, we describe radiosynthesis of [11C]4 and evaluation of its binding characteristics in post-mortem human brain autoradiography and with PET in cynomolgus monkeys. The 11C labelled 4 was synthesized by using [11C]methyltriflate in a methylation reaction with its phenolic precursor with good incorporation yield (64 ± 11%, DCY) and high specific radioactivity >370 GBq/μmol (>10 000 Ci/mmol). In post-mortem human brain autoradiography [11C]4 exhibited high specific binding in brain regions enriched with dopamine D2/D3 receptors and low level of non-specific binding. In cynomolgus monkeys [11C]4 exhibited high brain uptake reaching 4.4% ID at 7.5 min. The binding in the extrastriatal low density D2-receptor regions; thalamus and frontal, parietal, temporal, and occipital cortex, was clearly visible. Pre-treatment with raclopride (1 mg/kg as tartrate) caused high reduction of binding in extrastriatal regions, including cerebellum. [11C]4 is a promising radioligand for imaging D2 receptors in low density regions in brain.
We also recommend Trading Suppliers and Manufacturers of FLB 457 (cas 107188-66-9). Pls Click Website Link as below: cas 107188-66-9 suppliers
Prev:A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 (cas 107188-66-9) and [11C]WAY 100635
Next:The use of [18F]4-fluorobenzyl iodide (FBI) in PET radiotracer synthesis: Model alkylation studies and its application in the design of dopamine D1 and D2 receptor-based imaging agents) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 (cas 107188-66-9) and [11C]WAY 10063508/20/2019
- Regular ArticleError Analysis for Quantification of [11C]FLB 457 (cas 107188-66-9) Binding to Extrastriatal D2 Dopamine Receptors in the Human Brain08/19/2019
- Regular ArticlePET Mapping of Extrastriatal D2-like Dopamine Receptors in the Human Brain Using an Anatomic Standardization Technique and [11C]FLB 457 (cas 107188-66-9)08/18/2019
- Original articlePreparation of [76Br]FLB 457 (cas 107188-66-9) and [76Br]FLB 463 for examination of striatal and extrastriatal dopamine D-2 receptors with PET08/17/2019
- Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: A [11C]FLB 457 (cas 107188-66-9) PET study08/16/2019
- Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study08/15/2019
- Research reportExtrastriatal D2 and striatal D2 receptors in depressive illness: Pilot PET studies using [11C]FLB 457 (cas 107188-66-9) and [11C]raclopride08/14/2019
- Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457 (cas 107188-66-9)08/13/2019
- Biodistribution and radiation dosimetry in humans of [11C]FLB 457 (cas 107188-66-9), a positron emission tomography ligand for the extrastriatal dopamine D2 receptor☆08/12/2019


